Context |
•
Changing institutional support and federal funding |
|
•
Traditional academic structures promote silo based philosophies |
Tasks |
•
Scientific inquiry and production requiring high degree of autonomy, interdependence, multidisciplinary thinking, technology mediation, and knowledge management |
|
•
Acceleration of project to individual and population based health impact |
Individual Members |
•
Selection based on member personalities:
openness, self‐efficacy, scientific/academic/social capital |
|
•
Selection based on potential for high scientific and team skills |
Skill
Acquisition |
•
Core competencies in clinical and translational research |
|
• eadership development |
Team
Development |
•
Frequently nonlinear and based upon
opportunities and needs |
|
•
Based upon collaboration, exchange, active
engagement, and is subject to frequent reorientation |
Team
Structure |
•
Strategic core of team members maintains
scientific focus and continuity |
|
•
Loosely coupled networks of internal and external collaborators based on need |
Team
Processes |
• Agreed upon charter, vision, goals |
|
• Agenda based meetings/team documentation |
|
•
Internal and external collaboration/network creation |
|
• Clarity of roles and responsibilities |
|
•
Acknowledgment and resolution of conflicts and barriers |
|
• Focus on results and translational goals |
|
• Empowerment‐based leadership and support |
|
• Effective decision making and problem solving |
|
• Acknowledgement/use of expertise |
|
• Focus on development |
|
• Challenge of process and scientific inquiry |
Team Reactions and Affective States |
•
High self‐awareness, consensus on team model, knowledge of individual and team‐based expertise and capacities |
|
•
Strong commitment to team satisfaction, justice, efficiency, potency, and trust |
Team Evolution |
•
Continuous changes promote learning and adaptation |
|
•
Episodic, radical, and unexpected changes
creating disequilibrium based change and growth |
Team Performance |
•
Accelerated innovation and discovery to address human disease |
|
• Translation to population based health outcomes |